Cargando…
α-Synuclein promotes IAPP fibril formation in vitro and β-cell amyloid formation in vivo in mice
Type 2 diabetes (T2D), alike Parkinson’s disease (PD), belongs to the group of protein misfolding diseases (PMDs), which share aggregation of misfolded proteins as a hallmark. Although the major aggregating peptide in β-cells of T2D patients is Islet Amyloid Polypeptide (IAPP), alpha-synuclein (αSyn...
Autores principales: | Mucibabic, Marija, Steneberg, Pär, Lidh, Emmelie, Straseviciene, Jurate, Ziolkowska, Agnieszka, Dahl, Ulf, Lindahl, Emma, Edlund, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686322/ https://www.ncbi.nlm.nih.gov/pubmed/33235246 http://dx.doi.org/10.1038/s41598-020-77409-z |
Ejemplares similares
-
Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner
por: Sharma, Sandeep K., et al.
Publicado: (2015) -
Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance
por: Steneberg, Pär, et al.
Publicado: (2015) -
Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
por: Wasana Jayaweera, Sanduni, et al.
Publicado: (2021) -
On the Cluster Formation of α-Synuclein Fibrils
por: Dubackic, Marija, et al.
Publicado: (2021) -
The hot sites of α-synuclein in amyloid fibril formation
por: Khammari, Anahita, et al.
Publicado: (2020)